Clinical trial
Anti-HIV Medications and Structured Treatment Interruptions for People Recently…
NCT00084032 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00084032 |
|---|---|
| Title | Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV |
| Official title | A Randomized, Multicenter Trial to Determine Whether Induction Therapy Followed by Treatment Interruption is Superior to Induction Therapy Alone in the Treatment of Primary HIV Infection (PHI): The Structured Treatment Interruption (STI) Study |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral, Drug |
| Interventions | Structured treatment interruption, Antiretroviral regimen |
| Enrollment | 0 |
| First posted | Jun 7, 2004 |
| Last update posted | Oct 29, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: